Secondary malignant neoplasm of unspecified ovary refers to the presence of cancerous cells in the ovary that have metastasized from a primary tumor located elsewhere in the body. This condition is clinically significant as it indicates advanced disease and requires careful documentation for accurate diagnosis, treatment planning, and billing. The ICD-10 Code C79.60 facilitates precise coding for healthcare providers, ensuring compliance with billing standards and aiding in public health reporting.
ICD-10 Code C79.60 represents a secondary malignant neoplasm of the ovary that is unspecified, indicating that the cancer has spread to the ovary from another site. This code should be used when documenting cases where the primary site of cancer is known but the specific origin is not detailed. Accurate use of this code is essential for proper billing and to reflect the patient's clinical status in medical records.
Secondary malignant neoplasm of unspecified ovary occurs when cancer cells from a primary tumor spread to the ovary, leading to potential complications and requiring immediate medical intervention. This condition often signifies advanced cancer and necessitates thorough evaluation and management.
In SOAP notes, ICD-10 Code C79.60 is utilized to document the diagnosis of secondary malignant neoplasm of the ovary, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
ICD-10 Code C79.60 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of secondary malignant neoplasm of the ovary. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of secondary malignant neoplasm of unspecified ovary requires urgent medical attention, often necessitating hospitalization for comprehensive care.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C79.60 is critical in medical billing, particularly in hospital and oncology settings, to ensure accurate claims processing.
CPT Code | Description |
---|---|
99223 | Initial hospital care, typically 70 minutes or more of total time spent on the date of the encounter |
96413 | Chemotherapy administration, intravenous, push technique, single or initial substance/drug |
77021 | Magnetic resonance imaging, pelvis, with and without contrast material |
Common Questions About Using ICD-10 Code C79.60 for Secondary malignant neoplasm of unspecified ovary
What are the common symptoms of secondary malignant neoplasm of the ovary?
Common symptoms include abdominal pain, bloating, changes in bowel habits, and unexplained weight loss. Patients may also experience fatigue and other systemic symptoms related to cancer.
How is the diagnosis of secondary malignant neoplasm of the ovary confirmed?
Diagnosis is typically confirmed through imaging studies such as ultrasound or CT scans, along with biopsy of the ovarian mass to identify malignant cells.
What is the importance of accurate coding for C79.60?
Accurate coding for C79.60 is essential for proper billing, ensuring that healthcare providers are reimbursed for services rendered and that patient records reflect the severity of the condition.
Can C79.60 be used for billing in outpatient settings?
Yes, C79.60 can be used in outpatient settings, particularly when documenting follow-up care for patients with a known history of cancer and secondary involvement of the ovary.
Clinical Notes
SOAP notes
DAP notes
AI medical notes